Cargando…
Oncological hyperthermia: The correct dosing in clinical applications
The problem with the application of conventional hyperthermia in oncology is firmly connected to the dose definition, which conventionally uses the concept of the homogeneous (isothermal) temperature of the target. Its imprecise control and complex evaluation is the primary barrier to the extensive...
Autores principales: | Lee, Sun-Young, Szigeti, Gyula Peter, Szasz, Attila Marcell |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6317680/ https://www.ncbi.nlm.nih.gov/pubmed/30483754 http://dx.doi.org/10.3892/ijo.2018.4645 |
Ejemplares similares
-
Quo Vadis Oncological Hyperthermia (2020)?
por: Lee, Sun-Young, et al.
Publicado: (2020) -
The Clinical Validation of Modulated Electro-Hyperthermia (mEHT)
por: Lee, Sun-Young, et al.
Publicado: (2023) -
Hyperthermia versus Oncothermia: Cellular Effects in Complementary Cancer Therapy
por: Hegyi, Gabriella, et al.
Publicado: (2013) -
Review of the Clinical Evidences of Modulated Electro-Hyperthermia (mEHT) Method: An Update for the Practicing Oncologist
por: Szasz, Attila M., et al.
Publicado: (2019) -
Commentary on "Systematic review about complementary medical hyperthermia in oncology" by Liebl et al.
por: Arrojo, Elisabeth, et al.
Publicado: (2022)